PROMETHEUS BIOSCIENCES INC's ticker is RXDX and the CUSIP is 74349U108. A total of 2 filers reported holding PROMETHEUS BIOSCIENCES INC in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $71,906,546 | -36.7% | 670,020 | -35.1% | 1.32% | -41.1% |
| Q4 2022 | $113,623,180 | -27.9% | 1,032,938 | -61.3% | 2.24% | -27.7% |
| Q3 2022 | $157,513,000 | +72.6% | 2,669,255 | -17.4% | 3.10% | +58.8% |
| Q2 2022 | $91,259,000 | -25.2% | 3,232,700 | 0.0% | 1.95% | +2.0% |
| Q1 2022 | $122,067,000 | -15.9% | 3,232,700 | -13.6% | 1.91% | +3.2% |
| Q4 2021 | $145,120,000 | +70.5% | 3,742,507 | +0.8% | 1.85% | +65.1% |
| Q3 2021 | $85,139,000 | -3.5% | 3,714,032 | 0.0% | 1.12% | -5.2% |
| Q2 2021 | $88,191,000 | +34.5% | 3,714,032 | 0.0% | 1.18% | +21.9% |
| Q1 2021 | $65,568,000 | – | 3,714,032 | – | 0.97% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| UBS ASSET MANAGEMENT AMERICAS INC | 18,448 | $1,979,838 | 0.00% |
| FinTrust Capital Advisors, LLC | 13 | $1,430 | 0.00% |